FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/03/008077 [Registered on: 14/03/2017] Trial Registered Prospectively
Last Modified On: 27/02/2017
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A clinical trial to compare the effect of two drugs, dexmedetomidine and esmolol as blood pressure controlling agents in patients undergoing ENT surgeries.  
Scientific Title of Study   A comparative study to evaluate the efficacy of dexmedetomidine as a hypotensive agent in comparison to esmolol in ASA grade 1-2 patients undergoing ENT surgeries.  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shilpa Bansal  
Designation  Assistant professor 
Affiliation  Adesh university 
Address  Dept of Anaesthesiology and intensive care Adesh institute of medical sciences and research Adesh university Barnala road bathinda 151001 Punjab
Barnala road bathinda Punjab 151001
Bathinda
PUNJAB
151001
India 
Phone  09915433522  
Fax    
Email  Shilpa_shinde24@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shilpa Bansal  
Designation  Assistant professor 
Affiliation  Adesh university 
Address  Dept of Anaesthesiology and intensive care Adesh institute of medical sciences and research Adesh university Barnala road bathinda 151001 Punjab
Barnala road bathinda Punjab 151001
Bathinda
PUNJAB
151001
India 
Phone  09915433522  
Fax    
Email  Shilpa_shinde24@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shilpa Bansal  
Designation  Assistant professor 
Affiliation  Adesh university 
Address  Dept of Anaesthesiology and intensive care Adesh institute of medical sciences and research Adesh university Barnala road bathinda 151001 Punjab
Barnala road bathinda Punjab 151001
Bathinda
PUNJAB
151001
India 
Phone  09915433522  
Fax    
Email  Shilpa_shinde24@rediffmail.com  
 
Source of Monetary or Material Support  
Department of anaesthesiology and intensive care Adesh Institute of medical sciences, Adesh University, Barnala road bathinda 
 
Primary Sponsor  
Name  Dr Shilpa bansal 
Address  Assistant prof. Dept of anaesthesiology and intensive care, Adesh Institute of medical sciences,Barnala road bathinda Punjab  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr shilpa bansal  Dept of ENT and dept. of Anaesthesiology and Intensive care  adesh institute of medical sciences and research, adesh university, barnala road bathinda
Bathinda
PUNJAB 
9915433522

shilpa_shinde24@rediffmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical committee, Adesh University, bathinda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  ASA grade I-II patients of both sexes aged between 18-60 yrs, undergoing Otorhinolaryngeal (ENT) surgeries.,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  INJ. DEXMEDITOMIDINE  Patients in D group(assigned to receive dexmedetomidine ) will receive loading dose of 1 μg/kg dexmedetomidine diluted in 10 ml 0.9% saline infused over 10 min before starting of surgery, followed by continous infusion (0.4- 0.8 μg/kg/h).  
Intervention  INJ. ESMOLOL  Patients in E group (assigned to receive esmolol) patients will receive esmolol as a loading dose (1 mg/kg) infused over 1 min followed by continuous infusion of (0.4-0.8 mg/kg/h).  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients aged 18- 60 yrs of both the sexes, undergoing planned Otorhinolaryngeal (ENT) surgeries with ASA grade I-II. 
 
ExclusionCriteria 
Details  1.Patients refusing to give informed consent.

2.Patients with recurrent sinus surgery and patients with systemic co-morbidities like hypertension, coronory artery disease, renal or hepatic disease, cerebro vascular accidents.

3.Patients with coagulopathies or receiving drugs which have effects on coagulation profile.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
primary outcome is to compare the quality of the surgical field using a predefined category scale  surgical field score 
 
Secondary Outcome  
Outcome  TimePoints 
compare the efficacy and safety of dexmedetomidine with Esmolol as a hypotensive agent in ENT surgeries with attention on analgesia requirement, recovery profile, and tolerability in adult patients.   sedation score, visual analogue score, modified aldrete score 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/04/2017 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
This study is a prospective, randomised ,double blind, parallel group with active controlled trial to compare the efficacy and safety of dexmedetomidine with  Esmolol as a hypotensive agent in  60  (30 in each group) ASA grade I-II patients of both sexes aged between 18-60 yrs, undergoing Otorhinolaryngeal (ENT) surgeries with attention on the amount of blood loss, quality of the surgical field as primary outcome measures and analgesia requirement, recovery profile, and tolerability in adult patients as secondary outcome measures. 
 
Close